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amino acid changes between allelic MHC-binding pep-
tides (Loveland et al., 1990; Morse et al., 1996; Bhuyan
et al., 1997; Mendoza et al., 1997). T cell antigenicity
can also be influenced by biochemical changes to the
peptide antigen, including cysteinylation of cysteine-
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containing peptides (Meadows et al., 1997). More than²Department of Molecular and Cell Biology
60 autosomal minor H antigen encoding loci have beenUniversity of California
mapped in the mouse genome (http://www.informatics.Berkeley, California 94720
jax.org), and estimates of several hundred loci have
been made (Bailey, 1970). At least similar numbers are
expected in humans. It remains to be determined which
Summary T cell antigenicity mechanisms predominate.
While some progress is being made concerning the
Immune responses to minor histocompatibility anti- genetic mechanisms of antigenicity, the cellular function
gens are poorly understood and present substantial of the proteins from which minor H antigens are derived
barriers to successful solid tissue and bone marrow is quite poorly understood. The only examples in which
transplantation among MHC-matched individuals. We function has been elucidated are for the three cloned
exploited a unique positional cloning approach relying genes defining the mitochondrially encoded MTAs, all
on the potent negative selection capability of cytotoxic of which are known to play a role in energy metabolism
T cells to identify the H3a gene responsible for im- (Loveland et al., 1990; Morse et al., 1996, Bhuyan et al.,
munodominant H2-Db-restricted determinants of the 1997). The autosomally encoded minor H antigens have
classically defined mouse autosomal H3 complex. The been more elusive: while it is likely that such minor H
allelic basis for reciprocal H3a antigens is two amino peptide epitopes derive from proteins that perform a
acid changes within a single nonamer H2-Db-binding function unrelated to their histoincompatibility pheno-
peptide. The H3a gene, now called Zfp106, encodes a type, little is known about what these functions are.
1888±amino acid protein with three zinc fingers and The classically defined H3 locus on mouse chromo-
a b-transducin domain consistent with DNA/protein some 2 is the most intensely studied of all autosomal
binding. A region of ZFP106 is identical to a 600±amino minor H loci (Snell, 1958; reviewed in Michaelson, 1983,
acid sequence implicated in the insulin receptor sig- and Roopenian, 1999). H3 is immunologically and genet-
naling pathway. ically complex. While H3 spans 8±10 cM and contains
several genes that contribute to the histoincompatibility
phenotype, the only H2-Db-restricted cytotoxic determi-Introduction
nant elicited in immune responses between H3-con-
genic strains can be attributed to H3a (Roopenian andMinor histocompatibility (H) antigens pose a substantial
Click, 1980; Rammensee and Klein, 1983a; Kurtz et al.,barrier to solid tissue and bone marrow transplantation
1985; Roopenian and Davis, 1989; Zuberi et al., 1994).when donor and recipient are matched for the major
To map H3a, we exploited the fact that H3aa-antigenhistocompatibility complex (MHC; Graff and Bailey,
specific cytotoxic T lymphocytes (CTLs) impose a pow-1973; Goulmy et al., 1996; Perreault et al., 1996). These
erful selection against somatic cells heterozygously ex-antigens are short MHC-bound peptides that are alloan-
pressing this antigen (Zuberi et al., 1994, 1996). Escapetigenic to T cells and derived from normal cellular pro-
from CTL-mediated lysis frequently occurs via deletionteins (reviewed in Fischer Lindahl, 1991; Rammensee,
and/or mitotic recombination resulting in the loss of1994).
heterozygosity (LOH) for DNA markers surrounding H3a.Several minor H genes have been identified, and the
Genotyping of these LOH variants mapped H3a to a 1±2characterization of the minor H peptides encoded by
cM interval between D2Mit444 and B2m (Zuberi et al.,these genes have elucidated several mechanisms for T
1994, 1996). A yeast artificial chromosome (YAC) contigcell antigenicity (reviewed in Simpson et al., 1998). Some
was generated over this interval, and expression screen-minor H antigens are caused by the presentation of novel
ing of selected YAC clones localized H3a to a single YACantigens to individuals possessing an antigenically null
(Zuberi et al., 1998). In the current study, we describeallele as a result of extreme divergence of the gene
the cloning and characterization of H3a and explain theencoding the H antigen (e.g., HY antigens) (Scott et al.,
molecular basis by which a nonamer peptide results in1995; Wang et al., 1995; Greenfield et al., 1996; Markie-
allelic H3a antigens.wicz et al., 1998) or the failure to express the antigen-
encoding gene (e.g., H60) (Malarkannan et al., 1998). In
Resultscontrast, immune responses to several mitochondrially
encoded maternally transmitted antigens (MTAs) and
Physical and Genetic Mapping Surrounding H3athe autosomal mouse H13 antigen are caused by single
In previous studies, H3a was mapped to YAC M3H6
(Zuberi et al., 1998) positioned between Tyro3 and
Epb4.2 (encoding tyrosine kinase and erythrocyte pro-³ To whom correspondence should be addressed (e-mail: dcr@
jax.org). tein band 4.2, respectively). At the time, the only known
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Figure 1. Ordering of Loci Surrounding H3a
(A) Physical map and genetic maps. Mouse
chromosome 2 between the Tyro3 and
Epb4.2 genes is represented by the shaded
bar in the centromeric (left) to telomeric (right)
orientation (not to scale). The relative order
of genes (Tyro3, Capn3, and Epb4.2), mouse
homologs of human cDNAs (X523, X529, X67,
and X521), and mouse STS sequences (26±6,
26±7, 44±6, 43±7, 19±6, 7±7, 19±7, and 7±6)
are shown. The orientation of Capn3 on
mouse chromosome 2 is from Zuberi et al.
(1998). Immediately above the chromosome
is the STS marker content (indicated by trian-
gles) and inferred orientation of P1 clones
and YAC clone M3H6, which is known to carry
H3a. This YAC contains an internal deletion
(broken line) that includes Epb4.2 and X521
(Zuberi et al., 1998; unpublished data).
(B) Allele typing of the B10-derived chromosome 2 of H3aa antigen±loss immunoselection variants. Pluses indicate the presence of alleles;
minuses indicate the absence of alleles. For each locus, the nonimmunoselected 129-derived allele was present (data not shown). ND, not
typed. Variant 2B11 is representative of a class of fourteen antigen-loss variants (202±211, F10SL-6, F10SL-50, F11SL-22, and F11SL-36) that
demonstrate no LOH for any marker tested.
gene present on this YAC was Capn3 (encodes a subunit variants were useful in additional fine mapping studies
of H3a (described below).of a calpain protease). To further map H3a within the
extent of DNA cloned in M3H6, we needed to increase
the number of DNA markers positioned close to H3a.
Genomic Sequencing Distal to Capn3 IdentifiesAs this region of mouse chromosome 2 is syntenic to
a Candidate for H3ahuman chromosome 15q13±21 (DeBry and Seldin, 1996),
YAC M3H6 contains three known genes. These includeseveral human expressed sequence tags (ESTs), de-
Capn3 and two murine genes homologous to the humanscribed by Chiannilkulchai et al. (1995) and positioned
X529 and X67 genes. The LOH variant genotyping dataclose to the human CAPN3 gene, were used as hybrid-
eliminated the murine X67 and X529 homologs as H3aization probes to identify C57BL/6 (B6)-derived P1 clones
candidates. Capn3 was eliminated because cell linescarrying the homologous mouse genes. Additional P1
transfected with the B6-derived gene did not expressclones hybridizing to mouse Capn3 59 and/or 39 se-
the H3aa antigen (data not shown). Thus, we deducedquences (Richard and Beckmann, 1996; Zuberi et al.,
that H3a was a novel or unmapped gene positioned1998) were also identified. In Figure 1A, these clones
between the 39 end of Capn3 and STS 19±6. As P1±43are oriented with respect to each other in an order con-
and P1±44 contain DNA from this region, we searchedsistent with the human and mouse physical maps (Chi-
for additional genes by single-pass sequencing of theannilkulchai et al., 1995; Zuberi et al., 1998). Additional
genomic DNA within these P1 clones. Genomic se-sequence tagged site (STS) markers were generated
quences were then compared to cDNA sequences infrom the ends of P1 mouse clones.
the EST database.These STS markers and human genomic probes were
A gene was identified that was homologous to threethen used to refine the location of H3a on a panel of
overlapping mouse cDNA clones, EST 573507, 540229,somatic cell variants for which no LOH had been demon-
and 551557, derived from mid-stage mouse embryos,strated in earlier lower genetic resolution studies (Zuberi
thymus, and T cells, respectively. Alignment of cDNAet al., 1994, 1996). Genomic DNAs from (B10 3 129)F1-
and genomic sequences identified six exons (Figure 2A).or (B10 3 B10.LP)F1-derived H3aa antigen±loss variants
A consensus 1526 bp cDNA sequence was derived afterwere typed at each locus by Southern hybridization or
resequencing and alignment of cDNA clones 540229sequence-specific conformational polymorphism (SSCP),
and 551557 (Figure 2B; GenBank accession numbersusing enzymes or conditions that would discriminate
AF060245 and AF060244, respectively). The consensusbetween the B10 and the 129 or LP alleles. The results
sequence contains an open reading frame (ORF) initiat-are summarized in Figure 1B. LOH was detected in vari-
ing 59 of the available sequence and terminating at aants 2A12, 3D10, and C3±1. The LOH in variants 2A12
UGA stop codon (nucleotide [nt] 1020), located withinand 3D10 includes the complete Capn3 gene. The 2A12
the 532 bp exon. This exon also contains a region ofLOH extends from STS 26±7 to X521, and the LOH in
homology to EST BS51e, a human muscle±derived3D10 extends from STS 26±6 to 19±6. The LOH in variant
cDNA fragment (Chiannilkulchai et al., 1995; GenBankC3±1 extends from a region between exon 1 and exon
accession number Z47054). Additionally, the deduced24 of Capn3 to STS 19±7. Thus, the region of LOH com-
amino acid sequence of this ORF is homologous to themon to all three variants extends from exon 1 of Capn3
deduced polypeptide encoded by a human pancreatic(defined by C3±1) to 19±6 (defined by 3D10). Because
islet cDNA clone EST 339320 (data not shown). Becausethe LOH is causally related to the loss of the H3aa anti-
the tissue origin of many of these cDNAs is consistentgen, H3a must map between these two loci. However,
with the known wide tissue distribution of the H3a anti-even at this level of genetic resolution, several variants
gen, this gene was considered a candidate for H3a.including 2B11, 202±211, F10SL-6, F10SL-50, F11SL-
22, and F11SL-36 demonstrated no LOH. Some of these Positioned between this candidate gene and Capn3
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Figure 2. Genomic Sequencing Distal to Capn3 Identifies a Novel Gene
(A) Analysis of genomic DNA extending distally from the 39 UTR of Capn3 (black bar) toward the telomere. Vertical ticks demarcate 1 kb
intervals. Open bars identify regions of genomic DNA homologous to mouse cDNA clones within the EST database, identified by clone number
and tissue of origin. These cDNAs are predicted to be transcribed from the opposite DNA strand relative to Capn3 and most likely identify
alternatively spliced 39 UTRs of a gene located more distal from Capn3. The ORF of this gene is partially represented by the shaded bars and
identified by homology to three cDNA clones, which are listed as EST clone numbers. The extent and direction of transcription of this ORF
is shown by the black arrow. Six exons are shown. The sizes in base pairs of each exon is shown below the gene, and sizes in base pairs of
introns are shown above the gene. The genomic sequence was derived in two segments (GenBank accession numbers AF060242 and
AF060243) separated by .0.8 kb of genomic DNA. Three indicated EST clones contain an ORF to this gene.
(B) Consensus nucleotide sequence and predicted translation product of cDNA clones ESTs 551557, 540229, and 573507 (GenBank accession
Numbers AF060244, AF060245, and AA118879, respectively). EST 551557 extends from nt 1 to 1334, EST 540229 extends from nt 156 to
1526, and EST 573507 extends from nt 753 to 1407. Polymorphic nucleotides between cDNA clones EST 551557 and 540229 are indicated
by the boxed areas. In one case, polymorphism at nt 176 alters the deduced amino acid and both alleles are shown. Inverted triangles identify
intron±exon splice junctions. Locations of splice sites proximal to nt 491 are not known.
is a genomic region homologous to several overlapping cDNAs from the H3aa-expressing strains B6 and B10
and absent from the H3ab-expressing strains 129 andmouse EST cDNA clones. Nine representative cDNAs,
cloned from a wide array of tissues, are illustrated in LP. We used this restriction site polymorphism to screen
for allele-specific expression of this gene in the (B10 3Figure 2. None of these clones contain an ORF and all
are transcribed in the same direction as the H3a candi- 129)F1- and (B10 3 B10.LP)F1-derived H3aa antigen±
loss variants, for which no LOH had been found to date.date gene and in the opposite orientation to Capn3. One
cDNA clone, EST 875999, contains homology to two Four of fifteen variants screened did not express the
immunoselected B10 allele of this gene (Figure 3A). Ingenomic regions and is suggestive of alternative splic-
ing. The relationship between these cDNA fragments all cases, the nonimmunoselected 129-derived cDNA
continued to be expressed, as expected. When theseand the H3a candidate gene is not known; however,
they may represent alternative 39 untranslated region same variants were screened by SspI digestion of PCR
fragments that amplified genomic DNA from this same(UTR) sequences of the candidate gene.
region of the gene, all variants were still heterozygous
for both the B10 and 129 (or LP) alleles (Figure 3B). ThisAllele-Specific Expression Screening Identifies
H3aa Antigen±Loss Immunoselection Variants indicated that the four variants (202, 205, F10SL-50,
and F11SL-36) possessed a loss-of-expression (LOE)with Loss of Expression but not LOH
Four-nucleotide differences between cDNA clones EST phenotype, further implicating this gene as a candidate
for H3a.540229 and 551557 identify polymorphisms between the
mouse strains from which these ESTs were cloned (Fig-
ure 2B). One of these polymorphisms at nt 176 generates Zfp106 Encodes the H2-Db-Restricted H3aa Antigen
The complete 8462 bp cDNA of this gene was clonedan SspI restriction site in EST 540229 that is absent
in EST 551557. PCR amplification of cDNA with DNA by 59 RACE from B6-derived EL4 cDNA and designated
Zfp106 (encodes zinc finger protein 106, GenBank ac-primers flanking this region and restriction enzyme coin-
cubation demonstrated that the SspI site is present in cession number AF060246; see below). Further attempts
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Asn at position 5 (P5) of a nonamer peptide and a hy-
drophobic amino acid (Met, Leu, or Ile) at P9 (Ram-
mensee et al., 1995). The polymorphisms occur at posi-
tions P1 and P4 of the nonamer sequence encoding
ASPCNSTVL (ACL9) in B10 mice or TSPRNSTVL (TRL9)
in 129 mice. A third amino acid polymorphism was ob-
served in which a putative anchor Asp at P5 of the B10
GLLLNLKTSL (GNL10) sequence was replaced with Asp
in the 129 sequence GLLLDLKTSL (GDL10). The fourth
Ala/Thr polymorphism occurs within a region inconsis-
tent with known H2-Db binding motifs.
Four synthetic peptides (ACL9, TRL9, GNL10, and
GDL10) were scored for the ability to sensitize Db-trans-
fected TAP-deficient T2 target cells for lysis by the H3aa-
specific CTL clone Lpa/2R-1. Only ACL9-loaded target
cells were lysed (Figure 4D), thus establishing the iden-
Figure 3. Allele-Specific RT±PCR Identifies Loss of Expression
tity of the H3aa antigen. To confirm this, the HPLC elutionVariants
profiles of natural peptides and synthetic ACL9 were(A) Analysis of SspI-digested, RT±PCR amplified 763 bp cDNA frag-
compared. Fractionation of the complex pool of nativements from B10 and 129 Con A splenocytes, the parental (B10 3
peptides revealed one major peak that contained z90%129)F1 and (B10 x B10.LP)F1 cell lines, a control LOH variant, 2A12,
and H3aa antigen immunoselection variants lacking evidence for a of Lpa/2RZ hybridoma±stimulating activity (Figure 4E).
genetic loss. The B10-derived fragment contains two SspI sites, This peak coeluted with ACL9, demonstrating that this
and the 129 and B10.LP-derived fragments contain a single site. peptide is the predominant natural ligand for H3aa-spe-
The 433 bp SspI restriction fragment is diagnostic for the expression
cific T cells. Semiquantitative estimates of the abun-of the B10 allele of this gene.
dance of the natural H3aa antigen in (B10 3 129)F1 ex-(B) PCR amplification and SspI digestion of a 364 bp genomic DNA
tracts suggested z165 ACL9/H2-Db complexes per cell.fragment across the same polymorphic SspI site. The 245 bp frag-
ment identifies the B10 allele. The 129-derived PCR fragment con- Two minor peptide Lpa/2RZ stimulatory fractions were
tains no SspI site. Size standards (base pairs) are indicated. also observed eluting more rapidly than ACL9 from the
HPLC column. The nature of the peptides responsible
for the minor stimulatory activities is unknown.
The H3aa antigen, ACL9, contains a Cys at position 4to clone 59 cDNA did not generate any new products
(P4). This amino acid may be a site for posttranslationaland, therefore, it is likely that the cDNA cloned is close
cysteinylation, as reported recently for other Cys-con-to a full-length lymphoid transcript. Zfp106 contains a
taining peptides (Meadows et al., 1997). To determine5664 bp ORF, a 2291 bp 59 UTR, and a 507 bp 39 UTR.
whether native ACL9 could be modified by cysteinyla-The 39 UTR may differ among cell types if additional
tion in vivo, we compared the HPLC elution profiles ofputative 39 exons depicted in Figure 2 are utilized.
natural Lpa/2RZ-stimulatory peptides treated by coin-Plasmids expressing Zfp106 minigenes were tested
cubation with the reducing agent DTT with the elutionfor the ability to encode H3aa in H2-Db transfected COS
profile of untreated peptides. No differences were ob-cells (Figure 4A). Plasmid pAZ552 contains a 2114 bp
served (data not shown), suggesting that ACL9 is notcDNA fragment derived from the 59 end of the gene.
naturally cysteinylated. Moreover, cell-mediated lympho-This plasmid should express a truncated ZFP106 protein
lysis assays with two independently derived anti-H3aainitiating from the native start codon. Plasmids pAZ556
cloned CTLs performed against target cells presentingand pAZ563 were derived by subcloning of EL4-derived
either endogenous or synthetic H3aa peptides in theRT±PCR fragments into expression plasmids. The same
presence of DTT or in serum-free conditions showed no59 primer (designated START 2) containing a nonnative
evidence for cysteinylation (data not shown).AUG in-phase codon was used to initiate translation in
both minigene constructs. As can be seen in Figure 4B,
only pAZ556 and pAZ563 stimulated b-galactosidase Reciprocal CTL Responses Are Directed
production from the H3aa-specific Lpa/2RZ hybridoma against Allelic H3a Peptides
and, thus, demonstrate expression of H3aa. The antigen H2-Db-restricted CTLs are generated reciprocally in re-
must therefore be encoded within the 640 bp cDNA sponses between B10.LP and B10 mice. To determine
region shared by both plasmids. whether these reactivities could be attributed to the
As Zfp106 is expressed in both H3aa and H3anot a allelic ACL9 and TRL9 peptides, we analyzed the speci-
strains (Figure 3A), a reasonable explanation for immu- ficity of cloned and bulk effectors cells generated in
nogenicity of H3a is amino acid polymorphism in an H2- these strain combinations. Both the clone Lpa/2R-1 and
Db binding peptide. Thus, the nucleotide sequences of bulk B10.LP anti-B10 CTLs lysed T2-Db target cells
the 640 bp region from B10 and 129 Con A±stimulated loaded with ACL9 (Figures 5A and 5B), while a cloned
splenocyte cDNAs were compared. Figure 4C depicts line (B/L) and bulk culture of B10 anti-B10.LP CTLs lysed
the deduced amino acid alignment and the identification T2-Db target cells loaded with the allelic TRL9 peptide
of four polymorphic residues. Two of these occur within (Figures 5C and 5D). Therefore, these allelic peptides
a 9±amino acid sequence that contains similarity to an explain the reciprocal H2-Db-restricted CTLs. The pep-
tide concentration required for half-maximal lysis (C50)H2-Db class I MHC±binding motif consisting of an anchor
Positional Cloning of H3a
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Figure 4. Identification of the H3aa Antigen
(A) Extent of Zfp106 cDNA minigenes in expression plasmids. A depiction of the Zfp106 cDNA is shown. The ORF is shown as a stippled bar.
Below are shown the extents of cDNA cloned in specified expression vectors, in the appropriate orientation to allow expression. Plasmid
pAZ552 contains Zfp106 nt 2163±4277 in pcDNA3.1/Zeo(2). Plasmid pAZ556 contains nt 4154±7709, derived from PCR amplification of EL4
cDNA with primers START 2 and 59-TGCTGCCATCATAACAGCCAG-39, in pcDNA3.1/Zeo(1). Plasmid pAZ563 contains a nt 4154±4794 subclone
of pAZ556 in pcDNA3.1/Zeo(2).
(B) LacZ response of the H3aa-specific Lpa/2RZ hybridoma to Db-COS cells transfected with varying concentrations of the indicated plasmids.
The vector control shown is pcDNA3.1/Zeo(2).
(C) Comparison of the deduced amino acid sequences of the antigen-encoding region of ZFP106 (equivalent to the extent of cloned DNA in
pAZ563) between H3aa±expressing B10 and H3anot a±expressing 129 strains. Polymorphic amino acids are boxed.
(D) Response of H3aa-specific cloned CTL Lpa/2R-1 to T2-Db cells loaded with differing concentrations of the indicated peptides. Specific
lysis was determined at a 20 to 1 effector to target cell ratio.
(E) HPLC fractionation and coelution of synthetic ACL9 peptide with the major peak eluted from total extract of (B10 3 129)F1 pre-B cells.
Native peptide fractions were assayed for Lpa/2RZ-stimulating activity using Db-COS cells as APC. Mock indicates fractions collected in an
identical run with sample buffer alone. The arrow marks the retention time of ACL9 peptide under identical run conditions. The percent
acetonitrile concentration is indicated by the dashed line.
was reproducibly in the high picomolar to low nanomolar that this ACL9-specific CTL is absolutely dependent
upon Ala at P1 and Cys at P4 (Figure 5A). However, inrange, somewhat higher than the values reported for
the H2-Db-restricted H13 and Uty peptides (Greenfield bulk anti-H3aa culture, even though the preferred ligand
was ACL9, the P1-disparate TCL9 and to a lesser extentet al., 1996; Mendoza et al., 1997). In contrast to H13-
specific CTLs (Mendoza et al., 1997), none of the H3a- the P4-disparate ARL9 peptides were also recognized
(Figure 5B). While CTLs directed against H3ab TRL9 pep-specific CTLs appreciably lysed cells loaded with ªselfº
peptide, thus demonstrating a high degree of tolerance tide showed a similarly strong requirement for Arg at
P4, they demonstrated less of a requirement for theto self.
To gauge the relative importance of changes at P1 amino acid at P1 than did the anti-H3aa CTLs. The anti-
H3ab clone B/L and bulk culture lysed P1-disparateand P4 on T cell recognition, we analyzed two additional
nonamer peptides, TCL9 and ARL9, that differed from ARL9 peptide-loaded targets, albeit at concentrations
27 times and 2.5 times greater, respectively, than re-ACL9 and TRL9 by single amino acid differences at
either P1 or P4. Neither TCL9- or ARL9-loaded targets quired for the natural TRL9 peptide (Figures 5C and 5D).
Thus, recognition of the correct amino acid at P4 waswere lysed by anti-H3aa clone Lpa/2R-1, demonstrating
Immunity
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Figure 5. Clonal and Bulk CTL Reactivity to
Synthetic Peptides
H3aa-specific cloned line Lpa/2R-1 (A) and
bulk B10.LP anti-B10 CTLs (B), along with
H3ab-specific cloned line B/L (C) and bulk B10
anti-B10.LP CTLs (D), were incubated with
T2-Db target cells loaded with the indicated
concentrations of synthetic peptides. The
dashed line indicates the percent specific ly-
sis of allogeneic B10 (H3aa [A and B]) or
B10.LP (H3ab [C and D]) Con A targets. Synge-
neic target cells were not lysed above back-
ground levels (data not shown). Peptide con-
centrations required for half-maximal lysis
(C50) are indicated. All effector to target cell
ratios were 10:1. (E) H2-Db stabilization of
H3a analog synthetic peptides. TAP-deficient
RMA-S cells were incubated with varying
concentrations of the indicated synthetic
peptides and analyzed by FACS using an anti-
H2-Db Mab. WMHHNMDLI and ASNENMETM
are avidly binding H2-Db-binding HY and flu
peptides, respectively, and GNL10 is a nega-
tive control ZFP106 peptide.
critical, while P1 played a lesser and more varied role. H3a antigen are conserved between SPRET/Ei and
H3ab-expressing strains, the only difference being a con-Importantly, none of the observed differences in cytol-
ysis were due to the ability of the analog peptides to servative Val to Ala polymorphism.
Screening for human genes homologous to the mousebind to class I MHC. The peptide concentration required
for half-maximal H2-Db stabilization on RMA/S cells of H3a region identified one cDNA in the EST database,
clone 35G06 (GenBank accession number Z19503). Theall four peptides and known H2-Db-binding peptides
ASNENMETM and WMHHNMDLI, derived from influenza deduced amino acid sequence of this partial cDNA
spans ZFP106 amino acids 654±694, and multiple aminonucleoprotein (NP) and mouse Uty, respectively, were
in a similar range of 6±30 nM (Figure 5E). acid polymorphisms between human and mouse can
be seen, including four amino acid differences between
the mouse ASPCNSTVL H3a peptide and the humanPhylogenetic Analysis of the Region
TSPCNPIVR ortholog (Figure 6). Thus, although this re-Encoding H3a
gion appears conserved within mouse strains, it is quiteMinor H loci typically display limited antigenic polymor-
different between human and mouse.phism (Rammensee and Klein, 1983b; van Els et al.,
1992; Roopenian et al., 1993; den Haan et al., 1996,
1998). To determine the genetic basis of limited H3a Analysis of ZFP106
The deduced amino acid sequence of Zfp106 (Figure 7)antigenic polymorphism, the H3a peptide-encoding re-
gion of Zfp106 was sequenced from common laboratory suggests a large polypeptide containing 1,888 amino
acids and a predicted Mr of 208,851. The ZFP106 proteinand wild-derived strains of mice that had been pre-
viously typed for H3aa. All H3aa-expressing strains con- contains three C2H2-type zinc finger motifs (Figure 7A),
two of which are located at the NH3 terminus (aminotain the identical amino acid sequence (Figure 6). All
H3ab-expressing strains, with one exception, also ex- acids 7±29 and 45±67), and a third less-well-conserved
motif is positioned close to the COOH-terminus (aminopress the identical amino acid sequence, including the
TRL9 peptide. The exception is SPRET/Ei, an inbred line acids 1820±1843); the gene was designated Zfp106 be-
cause of these motifs. ZFP106 also contains a putativederived from Mus spretus, a species distinct from Mus
musculus. SPRET/Ei mice express ARL9 and identify a cytochrome c family heme-binding domain, CILCHI, at
amino acid residues 7±12 that overlaps with the firstthird naturally occurring allele at H3a, H3as, which is a
hybrid of the H3aa ACL9 and H3ab TRL9 peptides. H3ab- zinc finger domain (Figures 7A and 7B), and the region
located close to the C-terminal end of the protein con-specific CTLs recognize and lyse cells loaded with syn-
thetic ARL9 (Figures 5C and 5D), but do not recognize tains homology to the b-transducin gene family.
Comparison of ZFP106 with the Swissprot protein da-(B10 X SPRET/Ei)F1 (H3aa 3 H3as) target cells express-
ing physiological concentrations of the natural peptide tabase reveals a region of identity to a 600±amino acid
polypeptide designated SIRM (Son of Insulin Receptor(data not shown). Other amino acids surrounding the
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Figure 6. Sequence Comparison of ZFP106 Surrounding the H3a Subsequence
The deduced sequence of amino acids 656±664 of ZFP106 surrounding the H3a subsequence was derived from amplification products of
mouse genomic DNA using the START 2 and TCGGGAAGAAGCGTGCCTGGGGGCTG (nt 4469±4494) oligonucleotide primers. The first methio-
nine amino acid is nonnative. The murine consensus sequence is indicated, identical residues are shown as dots, and substitutions are
indicated in the single-letter code. The murine H3a subsequences and the orthologous region from human EST 35G06 are boxed. Strain
distribution of the H3a antigen from Roopenian and Davis (1989).
Mutant; Figures 7A and 7B), identified from the cloning Mechanisms Leading to Minor H Antigens
These studies provide a molecular explanation for howof a cDNA referred to as Sh3bp3 (Salvatore et al., 1998).
Comparison between the Zfp106 and Sh3bp3 nucleo- genetic variation leads to histocompatibility barriers.
The simple explanation for the H3aa and H3ab antigenstides and the inferred amino acid sequences (Figure 7B)
suggest that the amino terminus of SIRM was incorrectly is amino acid changes at P1 and P4 within a single H2-
Db binding nonamer peptide sequence. The requirementidentified, and that both Sh3bp3 and Zfp106 utilize the
same initiation codon (compare AF060246 and U59739). for P4 was observed to be more stringent, in agreement
with both structural and functional studies that suggestAdditionally, two frameshift discrepancies at the 39 end
of the region of homology account for the 12±amino the P4 amino acid side-chain is an important TCR con-
tact residue for H2-Db/peptide complexes (Young et al.,acid mismatch between ZFP106 amino acids 805±816
and SIRM amino acids 566±577. The last 11 amino acids 1994; Hudrisier et al., 1996). In contrast, the P1 amino
acid appears to have little solvent exposure, and a P1of SIRM and the 39 UTR sequence are actually derived
from an intron of Zfp106 starting within the codon for alanine has been demonstrated to form hydrogen bonds
with amino acids positioned within the H2-Db peptideArg-828 (Figure 7C). Correcting for sequence ambigu-
ities, SIRM thus appears to be a part of ZFP106. binding cleft (Young et al., 1994). However, in agreement
with studies on SV-40 peptides (Lippolis et al., 1995),
changes at P1 altered the peptide/H2-Db complex rec-Discussion
ognition by both anti-H3aa and H3ab CTLs. Indeed,
changes at P1 completely abolished recognition by theWe report the cloning and characterization of a novel
zinc finger motif containing gene, Zfp106, that encodes ACL9-specific clone Lpa/2R-1, showing that positions
not necessarily regarded as major TCR contact residuesthe allelic immunodominant H2-Db-restricted cytotoxic
epitopes of the mouse H3 minor H locus. The identifica- can be pivotal for TCR recognition.
Our findings strengthen the notion that many minortion of Zfp106 as a candidate gene was deduced after
screening a small panel of highly informative LOH- and H antigens will prove to be reciprocally antigenic. Like
H3a, allelic variants of H13 (Mendoza et al., 1997) andLOE-containing H3aa antigen loss immunoselection vari-
ants. DNA markers derived from the ends of mouse YAC at least one MTA (Loveland et al., 1990) are explained
by matched allelic peptides in which both donor andand P1 clones and genomic fragments originating from
the syntenic region of human chromosome 15 all served recipient express a core MHC-bound peptide in which
discrete amino acid changes at TCR contact residuesto increase the genetic density required to detect LOHs
and LOEs. The genetic resolution derived from these cause the peptides to be alloantigenic in minor H-dispa-
rate mice and self antigens in autologous mice. Impor-variants is remarkable. It surpassed that provided from
the screening of over 3000 recombinant chromosomes tantly, the majority of minor H antigen congenic mouse
strains for which the minor H gene is not yet knowngenerated from backcross and intercross mice (unpub-
lished data), and allele-specific expression analysis of display reciprocal histoincompatibility even though they
were originally selected on the basis of one way resis-LOE variants directly implicated Zfp106. CTL-mediated
immunoselection has also refined the mapping of genes tance to tissue or tumor transplantation (Graff and Bai-
ley, 1973; Bailey, 1975). It is possible that the majority ofon the Y chromosome and facilitated the identification
of Uty as encoding a H2-Db restricted H-Y antigen (King such minor H loci are explained by reciprocally antigenic
peptides rather that antigens encoded by distinct geneset al., 1994, Greenfield et al., 1996). In principle, when
coupled to growing mouse and human genomics re- within the congenic segments. If most human autosomal
minor H loci are similarly explained, reciprocal reactivitysources, this technique could accelerate the identifica-
tion of any gene whose product is amenable to allelic- would be an important consideration in selecting HLA-
matched donors for bone marrow transplantation.specific selection in cultured cells.
Immunity
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Figure 7. Analysis of ZFP106
(A) Representation of the 1888 amino acids of ZFP106. C2H2 zinc finger motifs, the cytochrome C heme-binding domain (H), the H3aa nonamer
subsequence (asterisk), the region of amino acid homology with SIRM (black bar), and the region of homology to the b-transducin family
(stippled bar) are indicated.
(B) Amino acid sequence of ZFP106 and alignment with the reported amino acid sequence of SIRM. Regions of identity are boxed, and the
C2H2 motifs are underlined.
(C) Nucleotide and deduced amino acid sequence alignment between the C-terminal end and the 39 UTR region of Sh3bp3, with the B6-
derived genomic sequence of Zfp106 in the homologous region. A Zfp106 splice site following Arg-828 is marked, while the SIRM ORF was
proposed by Salvatore et al. (1998) to continue for an additional 11 amino acids before termination (asterisk). Nucleotide sequence disparities
between Zfp106 and Sh3bp3 are boxed. The size of the 39 UTR intron is polymorphic between the B6, 129, and BALB/c mouse strains
(GenBank accession numbers AF067397±AF067399), and Sh3bp3 is likely to be derived from the Swiss Webster mouse (data not shown;
compare GenBank accession numbers U59739 and AF067399).
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Sequence analysis of the region of Zfp106 encoding lymphocytes (this manuscript), brain, lung, kidney, and
adipocytes, with the highest levels of expression re-the H3a peptide provides a molecular explanation for
previous reports of limited polymorphism of mouse mi- ported in muscle and heart tissues (Chiannilkulchai et
al., 1995; Salvatore et al., 1998). Additionally, the tissuenor H antigens (Rammensee and Klein, 1983a; Roopen-
ian et al., 1993). In M. musculus strains, we found only origin of cDNA clones in the EST database suggest ex-
pression in 2-cell and late stage (day 14.5 dpc) embryos,two alleles of H3a, one encoding the ACL9 peptide and
the other encoding TRL9. Since M. spretus derived thymus, pancreatic islets, kidney, and mammary gland
(Figure 2A). Steady state levels of the 9 kb RNA transcriptSPRET/Ei mice express the distinct allele, the two alleles
within M. musculus strains are consistent with a single are elevated in insulin receptor±deficient mice, and coin-
cubation of hepatocytes with insulin leads to a reductionbifurcation that occurred after speciation. Limited anti-
genic polymorphism has also been reported for human in RNA expression (Salvatore et al., 1998). Whether insu-
lin-dependent regulation also occurs in lymphocytes re-minor H antigens (van Els et al., 1992; den Haan et al.,
1996, 1998). The amino acid differences between ACL9 mains to be determined.
SIRM could be a functional domain of ZFP106, andand TRL9 are nonconservative. The considerable amino
acid sequence divergence between mouse and human therefore the properties reported for SIRM are likely to
be a subset of those that apply to ZFP106. These includefurther suggests that the antigen-containing region of
ZFP106 does not lie within a conserved domain. More the ability to bind to FYN and Grb-2 and to be phos-
phorylated by FYN kinase (Salvatore et al., 1998). Thesegenerally, the results suggest that minor H antigens are
likely to emerge from coding sequences that are most activities would likely be modified by the adjacent
C2H2, cytochrome c heme binding, and b-transducintolerant to amino acid variation. These would be regions
outside of critical functional domains, perhaps in domain sequences. Additional experiments are required to un-
cover the true function of ZFP106. The fact that bothlinking regions.
alleles of Zfp106 express H3a antigens may make it
possible to exploit sequential CTL immunoselection to
The Function of Zfp106 and Other Minor H Genes elucidate this question.
The characterization of the complete Zfp106 cDNA
along with 39 genomic analysis provides a beginning Experimental Procedures
to understanding the true function of this prototypic
Miceautosomal minor H gene. The ZFP106 protein contains
All mouse strains were obtained from the production and/or re-three zinc finger C2H2 motifs, which have been impli-
search colonies at The Jackson Laboratory (Bar Harbor, ME). Geno-
cated as key regulators of cell growth and differentiation mic DNA was prepared from livers of the indicated mouse strains
via their putative role as transcription activators and/or or purchased from the DNA resource at The Jackson Laboratory.
H3aa-antigen expressing strains include C57BL/6 (B6) and C57BL/transcription repressors (Sauer and JaÈ ckle, 1991; Mar-
10 (B10). H3ab-expressing strains include 129/J (129) and LP/J (LP).golin et al., 1994). These activities are most likely potenti-
The congenic mouse strain B10.LP-H3b (B10.LP; genotype H3ab)ated by other proteins that interact with the observed
contains an LP-derived chromosome 2 segment on the B10 geneticcytochrome c heme binding and b-transducin domains
background. SPRET/Ei mice are an inbred line of the wild mouse
of ZFP106. The HY-encoding genes Smcy and Uty also species M. spretus.
encode proteins that are likely to be involved in protein
interaction and transcriptional regulation (Greenfield et Cell Lines
The H3aa-specific, H2-Db restricted CTL line Lpa/2R-1 (previouslyal., 1996; Kent-First et al., 1996). However, while there
C1) (Roopenian and Davis, 1989) and the H3ab-specific H2-Db re-is no reason to believe that these putative functions
stricted CTL line B/L, generated by immunizing B10.LP mice withrelate to the histoincompatibility phenotype, large, com-
B10 splenocytes (Zuberi et al., 1998), were passaged by weekly
plex proteins with several distinct functional domains subculture in FBS-supplemented Dulbecco's modified Eagle's me-
may tolerate more amino acid variation in noncritical dium (DMEM) as described (Roopenian and Davis, 1989). The H3aa-
specific, H2-Db restricted T cell hybrid Lpa/2RZ was generated byregions.
fusing Lpa/2R-1 with the BWZ.36/CD8 hybridoma as describedA 589±amino acid sequence within ZFP106 is essen-
(Sanderson and Shastri, 1994). TAP-deficient human T2 cells ex-tially identical to the recently described Sh3bp-encoded
pressing H2-Db (T2-Db) and mouse RMA/S cells (genotype H2b) were600±amino acid SIRM polypeptide. However, Salvatore
kindly provided by P. Cresswell (Yale University, CT) and S. Nathen-
et al. (1998) found no evidence of a 3.66 kb RNA tran- son (Albert Einstein Medical College, NY), respectively. The (B10 3
script predicted from the size of the Sh3bp3 cDNA on 129)F1 C3 and (B10 3 B10.LP)F1 Abelson mouse leukemia virus±
transformed lymphoblastoid cell lines used for targets of immuno-Northern blots. Our data suggest that this gene utilizes
selection were produced from cultures of bone marrow cells asa different initiation codon and contains an additional
described (Zuberi et al., 1994). All transformed cell lines were pas-239 amino acids of amino terminal sequence. Addition-
saged weekly in DMEM containing 5% bovine serum. For bulk CTLally, the terminal 11 amino acids of SIRM are encoded
populations, B10 and B10.LP mice were immunized i.p. with 2 3
by an intron for the lymphoid form of Zfp106. This sug- 107 splenocytes from B10.LP and B10, respectively. After 7±14 days,
gests that SIRM was inferred from either an alternatively primed responder cells were harvested and restimulated in MLC
with the 5 3 106 200 Gy irradiated spleen cells from the mouse strainor inappropriately spliced RNA. Sh3bp was found to
used for immunization in medium supplemented with 10±30 U/mlonly hybridize to a 9 kb RNA transcript (Salvatore et al.,
recombinant IL-2 in DMEM using established conditions (Roopenian1998). The size of this transcript is consistent with
et al., 1993).Zfp106 cDNA and is also consistent with the 9 kb BS51e
RNA transcript, the human homolog of Zfp106 (Chiannil- H3aa-Loss Immunoselection Variants
kulchai et al., 1995). The generation of H3aa antigen±loss variants 2A12, 2B11, and 3D10
derived from the (B10 3 129)F1-derived lymphoblastoid line C3 hasZfp106 appears to be expressed broadly, including
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Table 1. PCR Primers Used to Amplify Indicated Human or Mouse Genomic Template DNA for P1 Screening and Genotyping of H3aa
Antigen-Loss Immunoselection Variants
Size of Genomic
Tempa DNA PCR Product
STS ID STS Origin/Reference F (59-39) R (59-39) (8C) (bp) Polymorphismb
7±6 P1-7 Sp6 end TATGAGAACTTAAGTGCCTGG TACCGTGTGTTATCAACTGC 60 Mouse (432) np (SSCP)
7±7 P1-7 T7 end GGATCAGGTATCACCACTGTG CTAGGCTCCTGGGTGGACTCG 60 Mouse (330) SSCP
19±6 P1-19 Sp6 end TTGCCTACAGGCTATGGTGAC AAAGGCAGAGGAGGGTAGGGC 60 Mouse (261) RFLP (BglII)
19±7 P1-19 T7 end GATCTGCTGTTGTTCTTACTC CAGATACAAATCTCCCATGAC 60 Mouse (182) RFLP (PstI)
26±6 P1-26 Sp6 end ACTGCGGCACACTCAGGCTTC CCGGATCTGCAGGCTGCAAGC 60 Mouse (224) SSCP
26±7 P1-26 T7 end GGGAATCGTAATGATGGGCAG ACAGTTGTTGATTTGGCTGGA 60 Mouse (279) SSCP
43±7 P1-43 T7 end CCTGCAGTGTTGGTCTTGCAG GGATAGTAGCTTCACAGAAAC 60 Mouse (351) SSCP
44±7 P1-44 T7 end GACCTGGCTGGCCTAGAGCTC ACTGTGAGTTTCAGAACAGCC 60 Mouse (318) SSCP
X523 Chiannilkulchai et al. (1995) CCAGGAAGAGCGGATTTTAC ACTCCATTGGGGTATCTTGC 52 Human (1400) RFLP (BglII)
X529 Chiannilkulchai et al. (1995) GGAGAGCTTGGTGGTTGTGA GCTCCCTGGAATCCATTGTC 58 Human (180) RFLP (TaqI)
X67 Chiannilkulchai et al. (1995) TAAGCCCATCCAGACAGCAA AAAAGAAATCCCGTGCTGCT 56 Human (400) np (RFLP)
X521 Chiannilkulchai et al. (1995) CCCTCCAATACTTCACCAGC TTATCTCGTGAGCGGTATCG 50 Human (222) RFLP (TaqI)
a Annealing temperature for PCR amplification.
b Polymorphism between B10 and 129 mouse DNAs.
Designation ªnpº denotes a non-polymorphic marker. Parentheses refer to the assay used. RFLP, restriction fragment length polymorphism
with the indicated restriction enzyme; SSCP, single-stranded conformational polymorphism between parental B10 and 129 DNAs.
been described (Zuberi et al., 1994, 1996, 1998). Immunoselection GGGACA-39 (nt 993±7014) and 59-GTCAGGAGGATTAATTCTGGC-
39 (positioned within an intron) amplify a 364 bp genomic DNA frag-variant C3±3 and variants 202±211 were derived in a similar manner,
except that the variants may not have arisen from independent ment that spans the same polymorphic SspI restriction site. Diges-
tion of the B10-derived DNA with SspI yields two fragments of 245mutational events. Variants F10SL-6 and -50 and variants F11SL-
22 and -36 were generated from similar immunoselection of the and 119 bp. There is no SspI site in the 129- or LP-derived PCR
fragments.(B10 3 B10.LP)F1 lymphoblastoid cell line. All variants continued
to express nonimmunoselected H3ab H2-Db-restricted minor H anti-
gens (data not shown).
Rapid Amplification of cDNA Ends
Poly(A)1 RNA was purified from the EL4 cell line using a total RNA
isolation kit and oligo (dT) Sepharose column chromatography, bothMouse Bacteriophage P1 Library Screening
purchased from Life Technologies. The adaptor-linkered, double-A B6-derived bacteriophage P1 genomic library (Francis et al., 1994),
stranded (ds) cDNA library was constructed with a Marathon cDNAspotted at high density on nylon membranes, was screened by
amplification kit (Clontech, CA) following suggested protocols. Thehybridization with mouse and human DNA probes. The following
only modification was to use 200 U/mg poly(A)1 RNA SuperscriptP1s, listed as clone and coordinate, were characterized by STS
RT (GIBCO BRL) instead of the supplied Moloney leukemia viruscontent mapping and direct nucleotide end sequencing with T7 and
supplied enzyme in the kit. Two adaptor-linked cDNA libraries wereSp6 specific oligonucleotide primers: P1±7, ICRFP703 M20172 QD2;
made. One was derived from oligo dT±primed poly(A)1 RNA, andP1±19, ICRFP703 G1612 QD2; P1±26, ICRFP703 H20318 QD2; P1±
the second from random hexamer-primed poly(A)1 RNA. Rapid am-42, ICRFP703 J24229 QD2, P1±43, ICRFP703 D2186 QD2; and P1±
plification of cDNA ends (RACE) cloning of 59 Zfp106 cDNA was44, ICRFP703 DO8133 QD2.
carried out as recommended by Clontech using nested Zfp106-
specific primers and 59 AP1 and AP2 primers supplied with the
DNA Markers for Genotyping P1s Clontech amplification kit. RACE-derived cDNA fragments were gel-
and Immunoselection Variants purified and ligated to pCR2.1 (Invitrogen, CA) prior to sequencing.
DNA markers are listed in Table 1. The origin of these fragments was confirmed by mapping them
to the H3a genomic region, and colinearity of the amplified cDNA
fragments was confirmed by the generation of PCR products from
RT±PCR EL4 or B6 Con A±activated splenocyte-derived cDNA using one
Total RNA was prepared from 1±2 3 106 Con A±activated spleno- oligonucleotide primer derived from each new RACE product, and
cytes using an RNA isolation kit purchased from Clontech. Oligo dT the second primer anchored within cDNA previously established as
and random primed cDNA were separately generated using 1 mg being derived from Zfp106. These PCR fragments (amplified by high-
of total RNA and 200 U Superscript (Life Technologies) reverse fidelity Pfu DNA polymerase [Stratagene, CA]) were sequenced and
transcriptase (RT) in a volume of 20 ml containing RNase inhibitors compared to the sequence of the RACE product. All sequence ambi-
(Promega, Madison, WI). Incubation was at 428C for 60 min. RNase- guities were fully resolved.
free water (80 ml) was added, and 5 ml was typically used for PCR.
For allele-specific RT±PCR, a polymorphic SspI site at nt 7109 of
Zfp106 (present in B10 and B6, but absent in 129 and LP strains) was Expression Cloning of Minigene Constructs
EL4-derived Zfp106 cDNA fragments were subcloned into the In-used to visualize allele-specific expression. The restriction enzyme
polymorphism arises as a result of an A to G nucleotide difference vitrogen expression plasmids, pcDNA3.1/Zeo(1) or pcDNA3.1/
Zeo(-), as appropriate. For the two minigene constructs lacking thebetween the B10 and 129 alleles at nt 7112 of Zfp106. A 763 bp
cDNA fragment was amplified with primers 59-CAGCAGACACAACT 59 end of Zfp106, a 59 PCR primer, designated START 2, was synthe-
sized with the following sequence (59-CTATGGAAGGTGTGGCTTCAGTCCGGG-39 (nt 6948±6968) and 59-TGCTGCCATCATAACAGC
CAG-39 (nt 7689±7709). A nonpolymorphic SspI site (nt 7544) is pres- CTGACC-39). This primer contained an additional 5 bases (under-
lined) to allow for the translation of the mini-gene construct froment within the amplified fragment from all strains. Digestion of the
B10 allele with SspI generates three fragments of 170, 433, and 160 the nonnative, in-phase ATG codon. The procedures described by
Sanderson and Shastri (1994) were followed to transiently transfectbp. Digestion of the 129- and LP-derived alleles results in only two
fragments of 603 and 160 bp. The primers 59-GTGTTGGTGTCTTTGA plasmids into Db-COS cells and to screen for H3aa antigen.
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DNA Sequencing minor histocompatibility antigens between human and non-human
primates. Eur. J. Immunol. 26, 2680±2685.Sequencing reactions were performed by The Jackson Laboratory
Microchemistry Service and resolved on an Applied Biosystems den Haan, J.M., Meadows, L.M., Wang, W., Pool, J., Blokland, E.,
Model 373 Stretch automated fluorescent DNA sequencer. Primers Bishop, T.L., Reinhardus, C., Shabanowitz, J., Offringa, R., Hunt,
were synthesized by Ransom Hill (CA) or the Great American Gene D.F., et al. (1998). The minor histocompatibility antigen HA-1: a dial-
Company (CA). PCR-amplified cDNA fragments generated after am- lelic gene with a single amino acid polymorphism. Science 279,
plification with Pfu DNA polymerase (Stratagene, CA) were sub- 1054±1057.
cloned into plasmid pCR2.1 using the TA cloning kit (Invitrogen, Fischer Lindahl, K. (1991). Minor histocompatibility antigens. Trends
CA). Two or three independent clones were sequenced to ensure Genet. 7, 219±224.
the absence of PCR-induced sequencing errors.
Francis, F., Zehetner, G., Hoglund, M., and Lehrach, H. (1994). Con-
struction and preliminary characterization of the ICRF human P1Synthetic Peptides
library. Genet. Anal. Tech. Appl. 11, 148-157.All peptides were synthesized by Research Genetics. Purity (typi-
Goulmy, E., Schipper, R., Pool, J., Blokland, E., Falkenburg, J.H.,cally .80%) was determined by HPLC analysis and mass spectro-
Vossen, J., Grathwohl, A., Vogelsang, G.B., van Houwelingen, H.C.,metric analysis.
and van Rood, J.J. (1996). Mismatches of minor histocompatibility
antigens between HLA-identical donors and recipients and the de-HLPC Fractionation of the Native H3aa Antigen
velopment of graft-versus-host disease after bone marrow trans-Total acid-soluble peptides were purified from the (B10 3 129)F1
plantation. N. Engl. J. Med. 334, 281±285.lymphoblastoid cell line, as described (Mendoza et al., 1997). The
peptide pool was purified by reverse phase high-pressure liquid Graff, R.J., and Bailey, D.W. (1973). The non-H-2 histocompatibility
chromatography (HPLC), and each fraction was tested for the ability loci and their antigens. Transplant. Rev. 15, 26±49.
to stimulate b-galactosidase activity in the Lpa/2RZ hybridoma cell Greenfield, A., Scott, D., Pennisi, D., Ehrmann, I., Ellis, P., Cooper,
line. Multiple runs were performed to confirm coelution of synthetic L., Simpson, E., and Koopman, P. (1996). An H-YDb epitope is en-
and native H3aa peptides. coded by a novel mouse Y chromosome gene. Nat. Genet. 14,
474±478.
Cell-Mediated Lympholysis
Hudrisier, D., Mazarguil, H., Laval, F., Oldstone, M.B.A., and Gairin,
Standard 4 hr 51Cr release assay was used to determine the sensitiv-
J.E. (1996). Binding of viral antigens to major histocompatibility com-
ity to lysis by CTL effectors (Roopenian et al., 1993). For peptide
plex class I H-2Db molecules is controlled by dominant negative
sensitization assays, T2-Db were labeled with 51Cr, coincubated with
elements at peptide non-anchor residues. J. Biol. Chem. 271, 17829±
the synthesized peptide at specified concentrations, washed in me-
17836.
dia, and then coincubated with clonal or bulk CTLs, as described
Kent-First, M.G., Maffitt, M., Muallem, A., Brisco, P., Shultz, J.,(Mendoza et al., 1997). Lysis of the targets was measured by 51Cr
Ekenberg, S., Agulnik, A.I., Agulnik, I., Shramm, D., Bavister, B., etrelease into the supernatant.
al. (1996). Gene sequence and evolutionary conservation of human
SMCY. Nat. Genet. 14, 128±129.Peptide-Dependent H2-Db Stabilization on RMA/S Cells
King, T.R., Christianson, G.J., Mitchell, M.J., Bishop, C.E., Scott, D.,Mouse Tap-deficient RMA/S cells were loaded by coincubation with
Ehrmann, I., Simpson, E., Eicher, E.M., and Roopenian, D.C. (1994).varying concentrations of synthetic peptides, as described (Men-
Deletion mapping by immunoselection against the H-Y histocompat-doza et al., 1997). The amount of H2-Db on the cell surface was
ibility antigen further resolves the Sxra region of the mouse Y chro-quantified by flow cytometry after staining with fluorescein isothio-
mosome and reveals complexity of the Hya locus. Genomics 24,thiocyanate±labeled 28±14±8 anti-H2-Db MAbs provided by The
159±168.Jackson Laboratory Flow Cytometry Service.
Kurtz, M.E., Graff, R.J., Adelman, A., Martin-Morgan, D., and Click,
R.E. (1985). CTL and serologically defined antigens of B2m, H-3Acknowledgments
region. J. Immunol. 135, 2847±2852.
We thank Jennifer Hackett for help during an undergraduate intern- Lippolis, J.D., Mylin, L.M., Simmons, D.T., and Tevethia, S.S. (1995).
ship, Shari Roopenian for technical support, and Elizabeth Simpson, Functional analysis of amino acid residues surrounding two neigh-
David Serreze, and Leslie Kozak for critical review. This research boring H-2Db-restricted cytotoxic T-lymphocyte epitopes in Simian
was supported by National Institutes of Health (NIH) grants RO1- virus 40 tumor antigen. J. Virol. 69, 3134±3146.
AI28802 and AI24544. The Microchemistry (DNA sequencing) and Loveland, B., Wang, C.-R., Yonekawa, H., Hermel, E., and Lindahl,
Flow Cytometry Services of The Jackson Laboratory are subsidized K.F. (1990). Maternally transmitted histocompatibility antigen of
by NIH Core grant CA34196. We dedicate this work to the memory mice: a hydrophobic peptide of a mitochondrially encoded protein.
of Dr. George Snell (1903±1997), the discoverer of the H3 locus. Cell 60, 971±980.
Malarkannan, S., Shih, P., Eden, P., Zuberi, A.R., Christianson, G.,
Received August 17, 1998; revised September 14, 1998. Roopenian, D., and Shastri, N. (1998). The molecular and functional
characterization of a dominant minor H antigen, H60. J. Immunol.
References 161, 3501±3509.
Margolin, J.F., Friedman, J.R., Meyer, W.K., Vissing, H., Thiesen,Bailey, D.W. (1970). Four approaches to estimating number of histo-
H.J., and Rauscher, F.J. III (1994). Kruppel-associated boxes arecompatibility loci. Transplant. Proc. 2, 32±38.
potent transcriptional repression domains. Proc. Natl. Acad. Sci.
Bailey, D.W. (1975). Genetics of histocompatibility in mice. I. New USA 91, 4509±4513.
loci and congenic lines. Immunogenetics 2, 249±256.
Markiewicz, M.A., Girao, C., Opferman, J.T., Sun, J., Hu, Q., Agulnik,
Bhuyan, P.K., Young, L.L., Lindahl, K.F., and Butcher, G.W. (1997). A.A., Bishop, C.E., Thompson, C.B., and Ashton-Rickardt, P.G.
Identification of the rat maternally transmitted minor histocompati- (1998). Long-term T cell memory requires the surface expression
bility antigen. J. Immunol. 158, 3753±3760. of self-peptide/major histocompatibility complex molecules. Proc.
Chiannilkulchai, N., Pasturaud, P., Richard, I., Auffray, C., and Beck- Natl. Acad. Sci. USA 95, 3065±3070.
mann, J.S. (1995). A primary expression map of the chromosome Meadows, L., Wang, W., den Haan, J.M.M., Blokland, E., Reinhardus,
15q15 region containing the recessive form of limb-girdle muscular C., Drijfhout, J.W., Shabanowitz, J., Pierce, R., Agulnik, A.I., Bishop,
dystrophy (LGMD2A) gene. Hum. Mol. Genet. 4, 717±725. C.E., et al. (1997). The HLA-A*0201-restricted H-Y antigen contains
DeBry, R.W., and Seldin, M.F. (1996). Human/mouse homology rela- a posttranslationally modified cysteine that significantly affects T
tionships. Genomics 33, 337±351. cell recognition. Immunity 6, 273±281.
den Haan, J.M., Bontrop, R.E., Pool, J., Sherman, N., Blokland, E., Mendoza, L.M., Paz, P., Zuberi, A., Christianson, G., Roopenian,
D., and Shastri, N. (1997). Minors held by majors: the H13 minorEngelhard, V.H., Hunt, D.F., and Goulmy, E. (1996). Conservation of
Immunity
698
histocompatibility antigen locus defined as a peptide/MHC class I Zuberi, A.R., Nguyen, H.Q., Auman, H.J., Taylor, B.A., and Roopen-
complex. Immunity 7, 461±472. ian, D.C. (1996). A genetic linkage map of mouse chromosome 2
extending from thrombospondin to paired box gene 1, including theMichaelson, J. (1983). Genetics of beta-2 microglobulin in the
H3 minor histocompatibility complex. Genomics 33, 75±84.mouse. Immunogenetics 17, 219±259.
Zuberi, A.R., Christianson, G.J., Dave, S.B., Bradley, J.A., andMorse, M.C., Bleau, G., Dabhi, V.M., Hetu, F., Drobetsky, E.A., Lin-
Roopenian, D.C. (1998). Expression screening of a yeast artificialdahl, K.F., and Perreault, C. (1996). The COI mitochondrial gene
chromosome contig refines the location of the mouse H3a minorencodes a minor histocompatibility antigen presented by H2-M3. J.
histocompatibility antigen gene. J. Immunol. 161, 821±828.Immunol. 156, 3301±3307.
Perreault, C., Jutras, J., Roy, D.C., Filep, J.G., and Brochu, S. (1996).
GenBank Accession NumbersIdentification of an immunodominant mouse minor histocompatibil-
ity antigen (MiHA). T cell response to a single dominant MiHA causes
Single-pass genomic nucleotide sequencing distal to Capn3 hasgraft-versus-host disease. J. Clin. Invest. 98, 622±628.
been deposited as accession numbers AF060242 and AF060243.Rammensee, H.-G. (1994). How the quest to identify minor histocom-
The revised and complete sequences of EST clones 551557 andpatibility antigens led to something more important. Behring. Inst.
540229 can be found under accession AF060244 and AF060245,Mitt. July, 11-6.
respectively. The B6-derived complete nucleotide sequence of
Rammensee, H.-G., and Klein, J. (1983a). Complexity of the histo- Zfp106 is deposited under accession number AF060246. The 129
compatibility-3 region in the mouse. J. Immunol. 130, 2926±2929.
allele of the H3a antigen-encoding region is deposited under ac-
Rammensee, H.-G., and Klein, J. (1983b). Polymorphism of minor cession number AF060247. The B6-, 129-, and BALB/c-derived nu-
histocompatibility genes in wild mice. Immunogenetics 17, 637±647. cleotide sequences of the intron between the codons for Zfp106
Rammensee, H.-G., Friede, T., and Stevanovic, S. (1995). MHC li- Arg-828 and Phe-829 are deposited under accession numbers
gands and peptide motifs: first listing. Immunogenetics 41, 178±228. AF067397±AF067399, respectively.
Richard, I., and Beckmann, J.S. (1996). Molecular cloning of mouse
canp3, the gene associated with limb-girdle muscular dystrophy 2A
in human. Mamm. Genome 7, 377±379.
Roopenian, D.C. (1999). Lessons from H3, a model autosomal mouse
minor histocompatibility locus. In Minor Histocompatibility Antigens,
D.C. Roopenian, E. Simpson, and E. Goulmy, eds. (Austin: Landis
Bioscience), in press.
Roopenian, D.C., and Click, R.E. (1980). A new cytotoxic lympho-
cyte-defined antigen coded for by a gene closely linked to the H-3
locus. Immunogenetics 10, 333±334.
Roopenian, D.C., and Davis, A.P. (1989). Responses against anti-
gens encoded by the H-3 histocompatibility locus: antigens stimu-
lating class I MHC- and class II MHC-restricted T cells are encoded
by separate genes. Immunogenetics 30, 335±343.
Roopenian, D.C., Davis, A.P., Christianson, G.J., and Mobraaten,
L.E. (1993). The functional basis of minor histocompatibility loci. J.
Immunol. 1561, 4595±4650.
Salvatore, P., Hanash, C.R., Kido, Y., Imai, Y., and Accili, D. (1998).
Identification of sirm, a novel insulin-regulated regulated SH3 bind-
ing protein that associates with Grb-2 and FYN. J. Biol. Chem. 273,
6989±6997.
Sanderson, S., and Shastri, N. (1994). LacZ inducible, antigen/MHC-
specific T cell hybrids. Int. Immunol. 6, 369±376.
Sauer, F., and JaÈ ckle, H. (1991). Concentration-dependent transcrip-
tional activation or repression by Kruppel from a single binding site.
Nature 353, 563±566.
Scott, D.M., Ehrmann, I.E., Ellis, P.S., Simpson, E., Agulnik, A.I.,
Bishop, C.E., and Mitchell, M.J. (1995). Identification of a mouse
male-specific transplantation antigen, H-Y. Nature 376, 695±698.
Simpson, E., Roopenian, D., and Goulmy, E. (1998). Much ado about
minor histocompatibility antigens. Immunol. Today 19, 108±112.
Snell, G.D. (1958). Histocompatibility genes of the mouse. II. Produc-
tion and analysis of isogenic resistant lines. J. Natl. Cancer Inst. 21,
843±877.
van Els, C.A., D'Amaro, J., Pool, J., Blokland, E., Bakker, A., van
Elsen, P.J., van Rood, J.J., and Goulmy, E. (1992). Immunogenetics
of human minor histocompatibility antigens: their polymorphism and
immunodominance. Immunogenetics 35, 161±165.
Wang, W., Meadows, L.R., den Haan, J.M., Sherman, N.E., Chen,
Y., Blokland, E., Shabanowitz, J., Agulnik, A.I., Hendrickson, R.C.,
Bishop, C.E., et al. (1995). Human H-Y: a male-specific histocompati-
bility antigen derived from the SMCY protein. Science 269, 1588±
1590.
Young, A.C.M., Zhang, W., Sacchettini, J.C., and Nathenson, S.G.
(1994). The three dimensional structure of H-2Db at 2.4 AÊ resolution:
implications for antigen-determinant selection. Cell 76, 39±50.
Zuberi, A.R., Dudley, M.E., Christianson, G.J., and Roopenian, D.C.
(1994). Gene mapping in a murine cell line by immunoselection with
cytotoxic T lymphocytes. Genomics 19, 273±279.
